FEED News & Events

ENvue Medical announced that a Virginia-based, 255-bed nonprofit regional medical center affiliated with the Mayo Clinic Care Network is now using the ENvue Navigation Platform. "The transition to a nursing-led bedside model reflects a growing focus on efficiency and patient-centered care across hospital systems," said Doron Besser, MD, Chief Executive Officer of ENvue Medical. "With ENvue, care teams can perform feeding tube placement at the bedside, shifting procedures from interventional radiology to trained nursing staff and supporting a more streamlined process that reduces reliance on resource-intensive departments while maintaining clinical precision."

ENvue Medical issued the following stockholder letter and corporate update: "2025 was a transformative year for ENvue Medical. Today, our Company is a commercially active medtech business trading on the Nasdaq Capital Market under the ticker "FEED." ENvue's mission is to improve patient safety and clinical workflow through proprietary technologies that deliver real-time guidance, intelligent navigation, and non-invasive therapeutic solutions... Our ENvue Navigation Platform is now commercially deployed across 39 U.S. hospitals, generating recurring revenue and becoming embedded in the daily workflows of clinicians who rely on it. We also continue to advance our Acoustic Therapeutic Platform through PainShield and UroShield, preserving valuable technology, commercial relationships and future optionality for stockholders... We believe we took the necessary steps in 2025 to build our foundation for the next phase of growth... 2026 Priorities 1. Accelerate ENvue Navigation Platform Adoption... 2. Advance Regulatory Milestones... 3. Scale At-Home and Non-Acute Enteral Solutions... In conclusion, we believe ENvue Medical is positioned in 2026 to become a stronger company with clearer focus, expanding commercial traction, two proprietary technology platforms, and a disciplined strategy for growth. Our navigation platform addresses a meaningful clinical need in a large market; our acoustic platform adds diversification and strategic optionality, and our team remains focused on execution."

ENvue Medical announced that the United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for the Company's patent application titled "Feeding Tube with Electromagnetic Sensor and Camera," Application No. 18/199,059. "We believe that this allowance reflects our long-term vision to evolve enteral access from blind or indirect methods to intelligent, visualized placement," said Doron Besser, MD, Chief Executive Officer of ENvue Medical. "Integrating electromagnetic guidance with direct internal visualization expands the clinical value of our platform and strengthens our ability to build a differentiated technology ecosystem. Upon issuance, we expect the patent to expand our intellectual property protection across both navigation and visualization, reinforcing the strength and breadth of our next-generation product development platform. We also expect it to further solidify our competitive positioning in the enteral access market and support the continued evolution of the ENvue(TM) Navigation Platform toward intelligent, visualized placement."

ENvue Medical announced the signing of a distribution agreement with U-Deliver to distribute ENvue's recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels. "We believe that our partnership with U-Deliver is an important step in scaling ENvue's over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care market," said Doron Besser, MD, Chief Executive Officer of ENvue Medical. "We're focused on providing patients and caregivers with reliable, safe solutions for feeding and medication delivery, and supporting continuity of care beyond the hospital. We're pleased to work with a partner that understands the needs of home and long-term care."